Mgr. Helena Peschelová
Research specialist - PhD student, Michal Šmída Research Group
Office: bldg. E35/142
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5875 |
---|---|
E‑mail: |
Total number of publications: 25
2023
-
CRISPR/Cas9 technology as a useful tool in the study of chornic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
CRISPR/Cas9 technology as a useful tool in the study of chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
Exploring the mechanisms of Venetoclax resistence via drug screening and genome-wide CRISPR screening.
Year: 2023, type: Conference abstract
-
Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells.
Year: 2023, type: Conference abstract
-
Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation.
Year: 2023, type: Conference abstract
-
Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening.
Year: 2023, type: Conference abstract
2022
-
Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML
Year: 2022, type: Conference abstract
-
Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
Frontiers in Cell and Developmental Biology, year: 2022, volume: 10, edition: February 2022, DOI
-
Prediction of novel treatment options for CLL and AML cells based on drug repurposing.
Year: 2022, type: Conference abstract
2021
-
CD19 promoter hypermethylation as means of antigen-negative escape to CART-19 therapy.
Year: 2021, type: Conference abstract